Application 125274
- Type
- BLA
- Sponsor
- IPSEN BIOPHARM LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DYSPORT | abobotulinumtoxinA | INJECTABLE; INJECTION | 500 UNITS/VIAL | No | No |
| 002 | DYSPORT | abobotulinumtoxinA | INJECTABLE; INJECTION | 300 UNITS/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |